Document Detail


Therapeutic implications of high-dose angiotensin receptor blocker monotherapy in mild-to-moderate hypertensive patients.
MedLine Citation:
PMID:  20720555     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Yuichiro Yano; Kazuomi Kario
Related Documents :
19563275 - Candesartan: widening indications for this angiotensin ii receptor blocker?
20660105 - Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo.
9687585 - Dependence of at1 angiotensin receptor function on adjacent asparagine residues in the ...
9826555 - Modulation of the vascular smooth muscle angiotensin subtype 2 (at2) receptor by angiot...
20332535 - Regulation of fgf21 expression and secretion by retinoic acid receptor-related orphan r...
16912195 - Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows incr...
Publication Detail:
Type:  Comment; Journal Article     Date:  2010-08-19
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  33     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-05     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  981-3     Citation Subset:  IM    
Affiliation:
Divisions of Community and Family Medicine, University of Miyazaki, Miyazaki, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II Type 1 Receptor Blockers / adverse effects,  therapeutic use*
Blood Pressure / physiology
Dose-Response Relationship, Drug
Humans
Hypertension / drug therapy*,  physiopathology
Severity of Illness Index
Tetrazoles / adverse effects,  therapeutic use*
Treatment Outcome
Valine / adverse effects,  analogs & derivatives*,  therapeutic use
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Tetrazoles; 137862-53-4/valsartan; 7004-03-7/Valine
Comments/Corrections
Comment On:
Hypertens Res. 2010 Oct;33(10):986-94   [PMID:  20686486 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differences in the prevalence of metabolic syndrome and levels of C-reactive protein after puerperiu...
Next Document:  Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer: a genetic association ...